Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 573

1.

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, Harder L, Hasenclever D, Kühn M, Lenze D, Lichter P, Martin-Subero JI, Möller P, Müller-Hermelink HK, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, Stürzenhofecker B, Szczepanowski M, Trautmann H, Wacker HH, Spang R, Loeffler M, Trümper L, Stein H, Siebert R; Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe.

N Engl J Med. 2006 Jun 8;354(23):2419-30.

2.

Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma.

Salaverria I, Zettl A, Beà S, Hartmann EM, Dave SS, Wright GW, Boerma EJ, Kluin PM, Ott G, Chan WC, Weisenburger DD, Lopez-Guillermo A, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Jaffe ES, Staudt LM, Müller-Hermelink HK, Campo E, Rosenwald A; Leukemia and Lymphoma Molecular Profiling Project (LLMPP).

Haematologica. 2008 Sep;93(9):1327-34. doi: 10.3324/haematol.13071. Epub 2008 Aug 12.

3.

Molecular diagnosis of Burkitt's lymphoma.

Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project.

N Engl J Med. 2006 Jun 8;354(23):2431-42.

4.

Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.

McClure RF, Remstein ED, Macon WR, Dewald GW, Habermann TM, Hoering A, Kurtin PJ.

Am J Surg Pathol. 2005 Dec;29(12):1652-60.

PMID:
16327438
5.

Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.

Barth TF, Müller S, Pawlita M, Siebert R, Rother JU, Mechtersheimer G, Kitinya J, Bentz M, Möller P.

J Pathol. 2004 Aug;203(4):940-5.

PMID:
15258997
6.

Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis.

Scholtysik R, Kreuz M, Klapper W, Burkhardt B, Feller AC, Hummel M, Loeffler M, Rosolowski M, Schwaenen C, Spang R, Stein H, Thorns C, Trümper L, Vater I, Wessendorf S, Zenz T, Siebert R, Küppers R; Molecular Mechanisms in Malignant Lymphomas Network Project of Deutsche Krebshilfe.

Haematologica. 2010 Dec;95(12):2047-55. doi: 10.3324/haematol.2010.026831. Epub 2010 Sep 7.

7.
8.

The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.

Salaverria I, Siebert R.

J Clin Oncol. 2011 May 10;29(14):1835-43. doi: 10.1200/JCO.2010.32.8385. Epub 2011 Apr 11. Review.

PMID:
21482997
9.

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ.

Mod Pathol. 2012 Jan;25(1):145-56. doi: 10.1038/modpathol.2011.147. Epub 2011 Oct 14.

10.

Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.

Aukema SM, Kreuz M, Kohler CW, Rosolowski M, Hasenclever D, Hummel M, Küppers R, Lenze D, Ott G, Pott C, Richter J, Rosenwald A, Szczepanowski M, Schwaenen C, Stein H, Trautmann H, Wessendorf S, Trümper L, Loeffler M, Spang R, Kluin PM, Klapper W, Siebert R; Molecular Mechanisms in Malignant Lymphomas Network Project.

Haematologica. 2014 Apr;99(4):726-35. doi: 10.3324/haematol.2013.091827. Epub 2013 Oct 31.

11.

Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.

Syrjänen S, Kallio P, Sainio P, Fuju C, Syrjänen K.

Scand J Dent Res. 1992 Jun;100(3):176-80.

PMID:
1321486
12.

Biology of the lymphomas: cytogenetics, molecular biology, and virology.

Ambinder RF, Griffin CA.

Curr Opin Oncol. 1991 Oct;3(5):806-12. Review.

PMID:
1661167
13.

Burkitt's lymphoma--the message from microarrays.

Harris NL, Horning SJ.

N Engl J Med. 2006 Jun 8;354(23):2495-8. No abstract available.

PMID:
16760450
14.

Development of a real-time reverse transcription polymerase chain reaction assay for c-myc expression that allows the identification of a subset of c-myc+ diffuse large B-cell lymphoma.

Sáez AI, Artiga MJ, Romero C, Rodríguez S, Cigudosa JC, Pérez-Rosado A, Fernández I, Sánchez-Beato M, Sánchez E, Mollejo M, Piris MA.

Lab Invest. 2003 Feb;83(2):143-52.

PMID:
12594230
15.

Epstein-Barr virus and Burkitt's lymphoma.

Magrath I, Jain V, Bhatia K.

Semin Cancer Biol. 1992 Oct;3(5):285-95.

PMID:
1335792
16.

[Molecular genetic features of sporadic Burkitt's lymphoma in children].

Yang WP, Huang H, Gong LP, Wu Y, Xu HY, Zou Y, Lü BB, Zhong HS, Deng QQ, Xiao Q, Zeng ST, Zhu CD.

Zhonghua Bing Li Xue Za Zhi. 2010 Dec;39(12):819-24. Chinese.

PMID:
21215097
17.

Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas.

Siebert R, Matthiesen P, Harder S, Zhang Y, Borowski A, Zühlke-Jenisch R, Metzke S, Joos S, Weber-Matthiesen K, Grote W, Schlegelberger B.

Blood. 1998 Feb 1;91(3):984-90.

18.

Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.

Kramer MH, Hermans J, Wijburg E, Philippo K, Geelen E, van Krieken JH, de Jong D, Maartense E, Schuuring E, Kluin PM.

Blood. 1998 Nov 1;92(9):3152-62.

19.

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project.

N Engl J Med. 2002 Jun 20;346(25):1937-47.

20.

Histogenetic correlations between subcategories of small noncleaved cell lymphomas.

Yano T, van Krieken JH, Magrath IT, Longo DL, Jaffe ES, Raffeld M.

Blood. 1992 Mar 1;79(5):1282-90.

Supplemental Content

Support Center